Cargando…
The US Food and Drug Administration's tentative approval process and the global fight against HIV
INTRODUCTION: In 2004, the US government began to utilize the Food and Drug Administration's (USFDA) tentative approval process (tFDA) as a basis to determine which HIV drugs are appropriate to be purchased and used in resource‐constrained settings. This process permits products that are not ap...
Autores principales: | Chahal, Harinder Singh, Murray, Jeffrey S, Shimer, Martin, Capella, Peter, Presto, Ryan, Valdez, Mary Lou, Lurie, Peter G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810328/ https://www.ncbi.nlm.nih.gov/pubmed/29232052 http://dx.doi.org/10.1002/jia2.25019 |
Ejemplares similares
-
Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment
por: Chahal, Harinder Singh, et al.
Publicado: (2018) -
An Evaluation of US Food and Drug Administration’s Program to Register HIV Drugs for Use in Resource-Constrained Settings
por: Chahal, Harinder Singh, et al.
Publicado: (2019) -
Use of US Food and Drug Administration Expedited Drug Development and Review Programs by Orphan and Nonorphan Novel Drugs Approved From 2008 to 2021
por: Monge, Andrea N., et al.
Publicado: (2022) -
Comparison of content of FDA letters not approving applications for new drugs and associated public announcements from sponsors: cross sectional study
por: Lurie, Peter, et al.
Publicado: (2015) -
Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020
por: Mitra-Majumdar, Mayookha, et al.
Publicado: (2022)